Table 1.
GENE SYMBOL | GENE NAME | FOLD CHANGE | FUNCTION | ACCESSION NUMBER |
---|---|---|---|---|
Cell-to-cell adhesion and communication
| ||||
FN1 | Fibronectin 1 | −2.6 | Involves cell adhesion, cell motility, wound healing. Possible role in metastasis | AW385690 |
DPI, DPII | Desmoplakin (DPI, DPII) | −2.3 | Intercellular junction, adhesion protein | M77830 |
| ||||
Cytokine and cytokine receptors
| ||||
BMP7 | Bone morphogenetic protein 7 (osteogenic protein 1) | −2.5 | Member of the transforming growth factor-beta superfamily, induces epithelial cell growth | BE395650 |
| ||||
Growth factor and receptors
| ||||
AREG | Amphiregulin (schwannoma-derived growth factor) | −2.0 | A member of the epidermal growth factor family, growth inhibition and stimulations | NM_001657 |
IGF1R | Insulin-like growth factor 1 receptor | −1.4 | Binds insulin-like growth factor, plays a critical role in transformation events. | X04434 |
| ||||
Signal transduction-related
| ||||
S100P | S100 calcium-binding protein P | −2.6 | Calcium-binding protein, mediates Ca2+ signals, overexpressed in breast cancer | BE536069 |
CALR | Calreticulin | 1.6 | Ca2+ binding protein, modulator of nuclear receptor function, possible role in angiogenesis | M84739 |
NUCB2 | Nucleobindin 2 | 2.8 | Ca2+ binding protein, possible role in calcium homeostasis | AF052644 |
| ||||
Chromatin remodeler and coactivator
| ||||
CITED2 | Cbp/p300-interacting transactivator | minus;1.7 | Coactivator of transcription factors | BF110899 |
SRC1 | Nuclear receptor coactivator 1 | −1.4 | Transcriptional coactivator for steroid and nuclear hormone receptors. | U59302 |
| ||||
Transcription factor
| ||||
EPAS1 | Endothelial PAS domain protein 1 | −2.3 | Transcriptional factor, induces VEGF expression, possible role in angiogenesis | AW377189 |
| ||||
Cell proliferation-related
| ||||
Ki-67 | Antigen identified by monoclonal antibody Ki-67 | −1.8 | Possible role in cell proliferation | X65550 |
p21 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1.7 | Cyclin-dependent kinase inhibitor, blocking cell cycle progression | U09579 |
| ||||
Development and differentiation-related
| ||||
NDRG1 | N-myc downstream regulated | −2.1 | A member of the N-myc downregulated gene family, possible role in growth arrest and cell differentiation, induced by hypoxia | X92845 |
| ||||
Metastasis-related
| ||||
IGFBP5 | Insulin-like growth factor binding protein 5 | −3.3 | Growth inhibitor and proapoptotic agent in breast cancer, possible role in metastasis | AA374325 |
FN1 | Fibronectin 1 | −2.6 | Cell adhesion, cell motility, wound healing. Possible role in metastasis | AW385690 |
EphA1 | EphA1 | −1.6 | Ephrin receptor subfamily of the protein-tyrosine kinase family, possible role in metastasis | Z27409 |
TIMP3 | Tissue inhibitor of metalloproteinase 3 | 1.9 | Natural inhibitors of the matrix metalloproteinases, inhibits VEGF binding to VEGFR2 and angiogenesis | AI095372 |
| ||||
Angiogenesis
| ||||
EPAS1 | Endothelial PAS domain protein 1 | −2.3 | Transcriptional factor, induces VEGF expression, possible role in angiogenesis | AW377189 |
NDRG1 | N-myc downstream regulated | −2.1 | A member of the N-myc downregulated gene family, induced by hypoxia | X92845 |
FN1 | Fibronectin 1 | −2.6 | Involves cell adhesion, cell motility, wound healing. Possible role in metastasis | AW385690 |
EphA1 | EphA1 | −1.6 | Ephrin receptor subfamily of the protein-tyrosine kinase family, possible role in metastasis | Z27409 |
CALR | Calreticulin | 1.6 | Ca2+ binding protein, modulator of nuclear receptor function, possible role in angiogenesis | M84739 |
TIMP3 | Tissue inhibitor of metalloproteinase 3 | 1.9 | Natural inhibitors of the matrix metalloproteinases, inhibits VEGF binding to VEGFR2 and angiogenesis | AI095372 |
Positive number of fold change represents the up-regulation of gene expression by melatonin.
Negative number of fold change represents the down-regulation of gene expression by melatonin.